Indonesia vs Panama: Malaria incidence per 1,000 population at risk
Indonesia
2.23 per 1,000 people
in 2024
Panama
3.5 per 1,000 people
in 2024
Indonesia rank
60th
Panama rank
58th
Malaria incidence per 1,000 population at risk over time
- Indonesia
- Panama
How they compare
Panama currently reports 3.5 per 1,000 people against 2.23 per 1,000 people in Indonesia, a difference of 1.27 per 1,000 people.
That makes Panama's figure about 1.6 times Indonesia's.
The two have swapped places 1 time across 25 shared years of data; in 2000 it was Indonesia ahead.
Indonesia ranks 60th and Panama ranks 58th of 120 countries.
Across the 3 decades both report, Indonesia averaged higher in 2 and Panama in 1.
Head to head by decade
| Decade | Indonesia | Panama | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 5.28 per 1,000 people | 1.06 per 1,000 people | 4.22 per 1,000 people | Indonesia |
| 2010s | 4.82 per 1,000 people | 0.3101 per 1,000 people | 4.51 per 1,000 people | Indonesia |
| 2020s | 1.9 per 1,000 people | 2.09 per 1,000 people | 0.1827 per 1,000 people | Panama |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher malaria incidence per 1,000 population at risk, Indonesia or Panama?
- Panama, at 3.5 per 1,000 people against 2.23 per 1,000 people in Indonesia as of 2024.
- What is the difference in malaria incidence per 1,000 population at risk between Indonesia and Panama?
- 1.27 per 1,000 people, with Panama ahead.
- How many years of comparable data are there for Indonesia and Panama?
- 25 years are reported by both, from 2000 to 2024.
- How do Indonesia and Panama rank globally for malaria incidence per 1,000 population at risk?
- Indonesia ranks 60th and Panama ranks 58th of 120 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Malaria incidence per 1,000 population at risk (per 1,000 population). Statizoid refreshes it automatically from the source and publishes the full history for both places.